GT Biopharma logo

GT Biopharma

GTBP | NASDAQ
Chart Builder DCF Calculator
$3.54
-$0.18 (-4.84%)
At close: Nov 16, 2026, 4:00 PM ET
$3.61
+$0.07 (+1.98%)
After-hours: Nov 16, 2026, 6:41 PM ET
-4.84%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
25
-1.5 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #929/1021 (Top 91%)

Key Statistics

Market Data

Market Cap $5.5M
1D Range
3.45 3.90
52W Range
3.45 23.00

Valuation (TTM)

PE -0.03
PB 1.54
EV/EBITDA -0.03

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. Their innovative approach centers...

Sector Healthcare
Industry Biotechnology
Employees 1
IPO Date Mar 27, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.